Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy
Authors
Keywords
-
Journal
Immunotherapy
Volume 8, Issue 9, Pages 1119-1134
Publisher
Future Medicine Ltd
Online
2016-08-03
DOI
10.2217/imt-2016-0019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytosolic Abnormally Hyperphosphorylated Tau But Not Paired Helical Filaments Sequester Normal MAPs and Inhibit Microtubule Assembly
- (2017) Khalid Iqbal et al. JOURNAL OF ALZHEIMERS DISEASE
- Chaperone-like Antibodies Targeting Misfolded Tau Protein: New Vistas in the Immunotherapy of Neurodegenerative Foldopathies
- (2017) Norbert Zilka et al. JOURNAL OF ALZHEIMERS DISEASE
- 2015 Alzheimer's disease facts and figures
- (2015) Alzheimers & Dementia
- Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
- (2015) Valeria Melis et al. BEHAVIOURAL PHARMACOLOGY
- Early investigational drugs targeting tau protein for the treatment of Alzheimer’s disease
- (2015) Keshav Anand et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Further understanding of tau phosphorylation: implications for therapy
- (2015) Miguel Medina et al. Expert Review of Neurotherapeutics
- Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
- (2015) Charles R. Harrington et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses
- (2015) Mallory Willet et al. JOURNAL OF INFECTIOUS DISEASES
- Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease
- (2015) Jing-Zhang Wang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling
- (2015) Natura Myeku et al. NATURE MEDICINE
- Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
- (2015) Sang-Won Min et al. NATURE MEDICINE
- Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice
- (2015) Meaghan Morris et al. NATURE NEUROSCIENCE
- Human secreted tau increases amyloid-beta production
- (2015) Jessica Bright et al. NEUROBIOLOGY OF AGING
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Further understanding of tau phosphorylation: implications for therapy
- (2015) Miguel Medina et al. Expert Review of Neurotherapeutics
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Structure and Mechanism of Action of Tau Aggregation Inhibitors
- (2014) Katryna Cisek et al. Current Alzheimer Research
- Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
- (2014) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
- (2014) Khalid Iqbal et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies
- (2014) Chun-ling Dai et al. JOURNAL OF NEURAL TRANSMISSION
- Biomarkers in dementia: clinical utility and new directions
- (2014) R M Ahmed et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
- (2014) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Direct cellular delivery of human proteasomes to delay tau aggregation
- (2014) Dong Hoon Han et al. Nature Communications
- Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Dimethyl fumarate: a Janus-faced substance?
- (2013) Frieder Kees EXPERT OPINION ON PHARMACOTHERAPY
- Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance
- (2013) Casey Cook et al. HUMAN MOLECULAR GENETICS
- Structural Determinants of Tau Aggregation Inhibitor Potency
- (2013) Kelsey N. Schafer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
- (2013) Alex Crowe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
- (2013) Erin E. Congdon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
- (2013) Jiaping Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells
- (2013) Jean-Marie Sontag et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NAP Alpha-Aminoisobutyric Acid (IsoNAP)
- (2013) Illana Gozes et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- Tau protein kinases: Involvement in Alzheimer's disease
- (2012) Ludovic Martin et al. AGEING RESEARCH REVIEWS
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
- (2012) Francesco Panza et al. Immunotherapy
- Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
- (2012) Najla Kfoury et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
- (2012) B. Zhang et al. JOURNAL OF NEUROSCIENCE
- Antibody-Aided Clearance of Extracellular -Synuclein Prevents Cell-to-Cell Aggregate Transmission
- (2012) E.-J. Bae et al. JOURNAL OF NEUROSCIENCE
- Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
- (2012) Alix de Calignon et al. NEURON
- Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?
- (2011) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Tau-targeted treatment strategies in Alzheimer's disease
- (2011) Jürgen Götz et al. BRITISH JOURNAL OF PHARMACOLOGY
- NAP (Davunetide) Provides Functional and Structural Neuroprotection
- (2011) Illana Gozes CURRENT PHARMACEUTICAL DESIGN
- Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease
- (2011) Michael Voronkov et al. Future Medicinal Chemistry
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Molecular Implication of PP2A and Pin1 in the Alzheimer's Disease Specific Hyperphosphorylation of Tau
- (2011) Isabelle Landrieu et al. PLoS One
- Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
- (2010) V. Frisardi et al. Current Alzheimer Research
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
- The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment
- (2010) Xiaochuan Wang et al. FASEB JOURNAL
- Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss
- (2010) Tetsuya Kimura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
- Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
- (2010) Anne Eckert et al. MOLECULAR NEUROBIOLOGY
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport: Fig. 1
- (2010) Keith A. Vossel et al. SCIENCE
- Mechanisms of tau-induced neurodegeneration
- (2009) Khalid Iqbal et al. ACTA NEUROPATHOLOGICA
- Chaperone-Like Antibodies in Neurodegenerative Tauopathies: Implication for Immunotherapy
- (2009) Eva Kontsekova et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease
- (2009) Lars M. Ittner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Propagation of Tau Misfolding from the Outside to the Inside of a Cell
- (2009) Bess Frost et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy
- (2009) Alix de Calignon et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- Amyloid- and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice
- (2009) V. Rhein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3 Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing
- (2008) Y. Wen et al. JOURNAL OF NEUROSCIENCE
- Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
- (2008) L. M. Ittner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide
- (2003) Merav Bassan et al. JOURNAL OF NEUROCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now